Alpha Tau Medical Ltd. (DRTSW) has a negative trailing P/E of -14.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 427.3 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -6.84%, forward earnings yield 0.23%. PEG 0.21 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
Overall SharesGrow Score: 38/100 with 1/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2019 | -80.7 | 0.00 | -3,538.74 | 0.00 | - |
| 2020 | -46.0 | -0.66 | -48.45 | 0.00 | - |
| 2021 | -14.6 | -0.07 | -11.44 | 0.00 | - |
| 2022 | -6.0 | 0.29 | 1.91 | 0.00 | - |
| 2023 | -7.1 | 0.34 | 2.46 | 0.00 | - |
| 2024 | -6.8 | -0.96 | 3.46 | 0.00 | - |
| 2025 | -9.4 | -0.53 | 5.17 | 0.00 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2019 | $-0.13 | $0.00 | $-8.46M | - |
| 2020 | $-0.22 | $0.00 | $-8.88M | - |
| 2021 | $-0.67 | $0.00 | $-27.27M | - |
| 2022 | $-0.53 | $0.00 | $-33.76M | - |
| 2023 | $-0.42 | $0.00 | $-29.16M | - |
| 2024 | $-0.45 | $0.00 | $-31.75M | - |
| 2025 | $-0.53 | $0.00 | $-42.63M | - |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.51 | $-1.03 – $-0.15 | $1.28M | $583.6K – $2.27M | 1 |
| 2027 | $-0.43 | $-0.86 – $-0.13 | $16.52M | $7.56M – $29.41M | 1 |
| 2028 | $0.00 | $0.00 – $0.00 | $72.34M | $33.11M – $128.81M | 1 |
| 2029 | $0.19 | $0.05 – $0.37 | $125.19M | $57.3M – $222.92M | 1 |
| 2030 | $1.00 | $0.30 – $2.01 | $259.02M | $118.56M – $461.22M | 1 |
